With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

Starting in October, drug companies will start rolling out generic versions of several widely used but expensive drugs. The top two sellers are the cholesterol drug Lipitor and the blood-thinner ...

PARIS/LONDON, Oct 5 (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday.

Bristol-Myers Squibb said generic competition on its biggest drug, Plavix, hamstrung third-quarter earnings, while a federal probe expanded to determine whether an ill-fated deal to protect the Plavix ...

Here's what's making health news this morning: FDA Approves Generic Version of Plavix (WSJ): The patent on the drug used to ward off heart attacks and strokes in people with cardiovascular disease ...

Last month's happy surprise in the pharmacy sector -- the launch of generic Plavix -- has turned into a question mark. A federal judge this week blocked Apotex, a private company in Canada, from ...

Shares of Bristol-Myers Squibb Co. sank more than 6 percent Tuesday as a generic drug maker disclosed it has begun selling a cheaper version of the big pharmaceutical company’s best-selling drug ...

Bristol-Myers Squibb Co. will ask a U.S. court to stop generic versions of its bestselling drug Plavix, four months after ousting its chief executive for bungling a deal to delay copycat versions of ...

In addition, there were no significant differences between the drug groups in the percent of patients who died or were hospitalized for any reason; had a stroke or transient ischemic attack ; or who ...